EP-1337 IMRT/VMAT vs. 3DCRT: the pathological and the clinical outcomes in LANSCLC treated with trimodality

Autor: Appel, S., Lawrence, Y.R., Symon, Z., Haisraely, O., Perlman, M., Ofek, E., Alezra, D., Katzman, T., Honig, N., Ben-ayun, M., Alezra, T. Rabin, Dubinsky, S., Kraitman, J., Tsvang, L.
Zdroj: In Radiotherapy and Oncology April 2019 133 Supplement 1:S732-S733
Databáze: ScienceDirect